Premarket trading saw a mixed session as several mega- and large-cap names moved sharply on analyst actions, deal developments, and upcoming earnings. Hewlett Packard Enterprise climbed after a Wall Street upgrade, Verisk Analytics slid following a court ruling tied to its AccuLynx acquisition, and Apple fell after a supply-chain check prompted a downgrade. Rocket Lab rose ahead of its second-quarter results, while Berkshire Hathaway edged higher after reporting stronger operating earnings growth.
Key takeaways
- Hewlett Packard Enterprise rose more than 5% after Morgan Stanley upgraded the stock to overweight, citing a more favorable risk/reward setup.
- Verisk Analytics fell more than 6.5% after a Delaware judge ruled the company must proceed with its $2.35 billion AccuLynx acquisition.
- Apple declined 1% after Jefferies downgraded the stock to underperform, citing supply chain checks that suggested an all-glass iPhone concept appears canceled.
- Rocket Lab gained nearly 3% as investors positioned ahead of Monday’s second-quarter earnings release.
- Intel slipped 1% after filing a proposal with the SEC that would allow it to offer sales of its common stock.
Analyst moves and supply-chain signals drove several names
Hewlett Packard Enterprise led premarket strength, climbing more than 5% after Morgan Stanley upgraded the stock to overweight from equal-weight. The bank said the company offers an attractive risk/reward profile and argued the market is underappreciating the relationship between Hewlett Packard Enterprise’s earnings power and its valuation.
Apple, by contrast, declined about 1% after Jefferies downgraded the stock to underperform from hold. According to Jefferies’ supply chain checks, analysts concluded that an all-glass iPhone—an approach Apple has never publicly announced—appears to be canceled. The downgrade adds pressure to Apple at a time when the company is looking to justify higher-priced devices amid rising costs for memory.
Intel fell about 1% after filing a proposal with the Securities and Exchange Commission to allow for the offering and sale of its common stock. The filing did not specify how many shares the company plans to offer as part of the proposed sale, leaving investors focused on how any potential capital plans could affect dilution and near-term financial flexibility.
Deal outcome weighs on Verisk; court ruling sets terms for acquisition
Verisk Analytics was the biggest decliner among the names highlighted, dropping more than 6.5% after a Delaware judge ruled that the company must proceed with its $2.35 billion acquisition of AccuLynx. The deal had been previously terminated in December after a Federal Trade Commission review of the merger was not completed by the transaction’s termination date.
The court’s decision effectively increases deal certainty in the near term, but the market reaction suggests investors were looking for more favorable odds or timing outcomes. For buyers, legal timelines can still translate into implementation risk, regulatory scrutiny, and potential deal-related costs—factors that can weigh on valuation even when the path forward becomes clearer.
Earnings expectations and operating updates shape price action
Rocket Lab rose nearly 3% in premarket as investors prepared for the company’s second-quarter earnings report, scheduled for release after the bell on Monday. Even with the premarket gain, the stock remains well off its recent peak: while shares had climbed nearly 60% during the referenced period, they were still down more than 40% from late-May highs. That context matters for traders and long-term investors alike, as upcoming results could determine whether the company can stabilize performance after a sharp run-up and subsequent pullback.
Berkshire Hathaway edged higher, up about 0.5%, after the company reported operating earnings growth of 16% in the second quarter. The report cited stronger results across manufacturing, services, and retailing earnings, along with growth in energy profits. Insurance was described as weaker, with investment income declining 9%, keeping attention on the mix of profitability drivers and the sensitivity of the insurance segment to investment conditions.
What investors are watching next
With Monday’s earnings release in focus for Rocket Lab, attention will likely shift quickly to guidance, margins, and any updates to near-term execution. For companies impacted by deal and capital-market developments, investors will also watch follow-through on the regulatory and legal path for Verisk’s AccuLynx transaction and any further details from Intel’s SEC filing that clarify the size and terms of its potential common stock offering. Apple’s trajectory will remain tied to device roadmap signals, while Hewlett Packard Enterprise will be monitored for whether upcoming results validate the upgrade thesis.
